.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The PROSEVA randomized trial demonstrated the importance of prolonged prone positioning in patients with severe acute respiratory distress syndrome. Mechanically ventilated adults with severe hypoxemia were assigned to prone positioning for at least 16 hours per day or to continued supine management, with both groups receiving lung-protective ventilation. Prone positioning significantly reduced 28-day mortality and also improved 90-day survival. The study helped establish prolonged prone sessions as a major component of evidence-based management for appropriately selected patients with severe ARDS. The result is particularly relevant to the NAPCON critical-care symposium, which includes awake proning, NIV failure and broader escalation strategies. For HCPs, the practical lesson is that proning is not simply a rescue maneuver performed for a few minutes; in severe ARDS, the studied benefit came from early, prolonged sessions delivered within a structured ventilatory strategy. Implementation requires staff training, airway security, pressure-injury prevention and monitoring for complications. The paper remains a landmark example of how a relatively simple bedside intervention can produce a large outcome effect when applied to the right physiologic phenotype.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The PROSEVA randomized trial demonstrated the importance of prolonged prone positioning in patients with severe acute respiratory distress syndrome. Mechanically ventilated adults with severe hypoxemia were assigned to prone positioning for at least 16 hours per day or to continued supine management, with both groups receiving lung-protective ventilation. Prone positioning significantly reduced 28-day mortality and also improved 90-day survival. The study helped establish prolonged prone sessions as a major component of evidence-based management for appropriately selected patients with severe ARDS. The result is particularly relevant to the NAPCON critical-care symposium, which includes awake proning, NIV failure and broader escalation strategies. For HCPs, the practical lesson is that proning is not simply a rescue maneuver performed for a few minutes; in severe ARDS, the studied benefit came from early, prolonged sessions delivered within a structured ventilatory strategy. Implementation requires staff training, airway security, pressure-injury prevention and monitoring for complications. The paper remains a landmark example of how a relatively simple bedside intervention can produce a large outcome effect when applied to the right physiologic phenotype.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
